Meta dissolves responsible AI division amid restructuring
Post Content
Post Content
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Post Views: 146
Post Content Post Views: 138
Post Content Post Views: 144
Post Content Post Views: 138
Post Content Post Views: 165
Post Content Post Views: 142